MedTrace Logo

Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant

NCT01060787 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 98

Last updated 2019-06-21

No results posted yet for this study

Summary

Investigate the impact of the Fluocinolone Acetonide (FA) intravitreal implants

Conditions

Interventions

PROCEDURE

Fluocinolone Acetonide 0.59 mg

At a single visit bilateral endothelial microscopy will be performed to determine endothelial cell density.

PROCEDURE

Fluocinolone Acetonide 2.1 mg

At a single visit bilateral endothelial microscopy will be performed to determine endothelial cell density.

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    lead INDUSTRY

Principal Investigators

  • Johnson Varughese · Valeant Pharmaceuticals/Bausch & Lomb

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-04
Primary Completion
2019-03-07
Completion
2019-06-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01060787 on ClinicalTrials.gov